ABCL
AbCellera Biologics Inc.
Company overview
- Market capitalization
- $4.27B
- Employees
- 562
- Latest publication
- 2026-09-29
About AbCellera Biologics Inc.
AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; AbbVie Inc.; Jazz Pharmaceuticals plc to develop T-cell engaging (TCE) multispecific antibodies; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 4,050,000USD | 8,955,000USD | 17,084,000USD | 4,235,000USD | 5,050,000USD | 6,507,000USD | 7,323,000USD | 9,954,000USD |
| Research Development | 45,987,000USD | 55,028,000USD | 39,213,000USD | 42,496,000USD | 46,076,000USD | 40,969,000USD | 40,927,000USD | 39,287,000USD |
| Selling General Administrative | 13,850,000USD | 22,052,000USD | 18,977,000USD | 16,226,000USD | 16,020,000USD | 19,147,000USD | 20,192,000USD | 17,352,000USD |
| Total Operating Expenses | 66,827,000USD | 85,233,000USD | 66,669,000USD | 66,895,000USD | 77,805,000USD | 100,170,000USD | 100,777,000USD | 64,848,000USD |
| Operating Income | -62,777,000USD | -76,278,000USD | -49,585,000USD | -62,660,000USD | -72,755,000USD | -93,663,000USD | -93,454,000USD | -54,894,000USD |
| Total Other Income Expense Net | 3,812,000USD | 7,510,000USD | 13,241,000USD | 9,676,000USD | 25,926,000USD | 31,031,000USD | 45,267,000USD | 12,147,000USD |
| Depreciation And Amortization | 6,990,000USD | 7,236,000USD | 7,060,000USD | 6,605,000USD | 13,900,000USD | 38,295,000USD | 38,037,000USD | 6,766,000USD |
| Income Before Tax | -58,965,000USD | -68,768,000USD | -36,344,000USD | -52,984,000USD | -46,829,000USD | -62,632,000USD | -48,187,000USD | -42,747,000USD |
| Income Tax Expense | -3,538,000USD | -11,649,000USD | -1,617,000USD | -7,363,000USD | -12,619,000USD | -11,525,000USD | -11,257,000USD | -2,137,000USD |
| Net Income | -55,427,000USD | -57,119,000USD | -34,727,000USD | -45,621,000USD | -34,210,000USD | -51,107,000USD | -36,930,000USD | -40,610,000USD |
| Gross Profit | — | 8,955,000USD | 17,084,000USD | 4,235,000USD | 5,050,000USD | 6,507,000USD | 7,323,000USD | 9,954,000USD |
| Selling And Marketing Expenses | — | 2,906,000USD | 3,009,000USD | 2,842,000USD | 3,144,000USD | 3,135,000USD | 3,136,000USD | 3,365,000USD |
| Unclassified Operating Expenses | — | 5,247,000USD | 5,470,000USD | 5,331,000USD | 12,565,000USD | 36,919,000USD | 36,522,000USD | 4,844,000USD |
| Interest Income | — | 6,765,000USD | 7,592,000USD | 8,051,000USD | 8,668,000USD | 9,603,000USD | 9,801,000USD | 10,401,000USD |
| Net Interest Income | — | 6,765,000USD | 7,592,000USD | 8,051,000USD | 8,668,000USD | 9,603,000USD | 9,801,000USD | 10,401,000USD |
| Tax Provision | — | -11,649,000USD | -1,617,000USD | -7,363,000USD | -12,619,000USD | -11,525,000USD | -11,257,000USD | -2,137,000USD |
| Net Income From Continuing Ops | — | -57,119,000USD | -34,727,000USD | -45,621,000USD | -34,210,000USD | -51,107,000USD | -36,930,000USD | -40,610,000USD |
| Ebit | — | -73,549,000USD | -45,893,000USD | -58,507,000USD | -69,211,000USD | -90,172,000USD | -90,144,000USD | -51,619,000USD |
| Ebitda | — | -66,313,000USD | -38,833,000USD | -51,902,000USD | -55,311,000USD | -51,877,000USD | -52,107,000USD | -44,853,000USD |
| Reconciled Depreciation | — | 7,236,000USD | 7,060,000USD | 6,605,000USD | 13,900,000USD | 38,295,000USD | 38,037,000USD | 6,766,000USD |
| Cost Of Revenue | — | — | 7,059,000USD | 42,496,000USD | 13,901,000USD | 38,295,000USD | 38,037,000USD | 6,766,000USD |
| Interest Expense | — | — | — | 8,051,000USD | — | — | — | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD |
|---|---|---|---|---|---|
| Total Revenue | 28,833,000USD | 38,025,000USD | 485,424,000USD | 233,155,000USD | 11,612,000USD |
| Cost Of Revenue | 96,999,000USD | 30,894,000USD | 66,436,000USD | 27,143,000USD | 10,113,000USD |
| Gross Profit | 28,833,000USD | 38,025,000USD | 418,988,000USD | 206,012,000USD | 11,612,000USD |
| Research Development | 167,259,000USD | 175,658,000USD | 107,879,000USD | 29,393,000USD | 10,113,000USD |
| Selling General Administrative | 72,711,000USD | 60,999,000USD | 55,485,000USD | 11,910,000USD | 2,749,000USD |
| Selling And Marketing Expenses | 12,779,000USD | 14,180,000USD | 11,270,000USD | 3,842,000USD | 1,263,000USD |
| Unclassified Operating Expenses | 90,850,000USD | 24,395,000USD | 27,843,000USD | 4,836,000USD | 1,604,000USD |
| Total Operating Expenses | 343,599,000USD | 275,232,000USD | 202,477,000USD | 49,981,000USD | 15,729,000USD |
| Operating Income | -314,766,000USD | -237,207,000USD | 216,511,000USD | 156,031,000USD | -4,117,000USD |
| Interest Income | 38,473,000USD | 42,247,000USD | 16,079,000USD | 293,000USD | 154,957USD |
| Net Interest Income | 38,473,000USD | 42,247,000USD | 12,034,000USD | -6,218,000USD | -54,239USD |
| Income Before Tax | -200,395,000USD | -174,029,000USD | 239,099,000USD | 157,833,000USD | -2,211,000USD |
| Income Tax Expense | -37,538,000USD | -27,631,000USD | 80,580,000USD | 38,915,000USD | 209,196USD |
| Tax Provision | -37,538,000USD | -27,631,000USD | 80,580,000USD | 38,915,000USD | — |
| Net Income | -162,857,000USD | -146,398,000USD | 158,519,000USD | 118,918,000USD | -2,211,000USD |
| Net Income From Continuing Ops | -162,857,000USD | -146,398,000USD | 158,519,000USD | 118,918,000USD | -2,210,696USD |
| Ebit | -301,146,000USD | -223,052,000USD | 227,065,000USD | 164,344,000USD | -2,002,000USD |
| Ebitda | -204,148,000USD | -192,158,000USD | 260,167,000USD | 169,615,000USD | -155,000USD |
| Depreciation And Amortization | 96,998,000USD | 30,894,000USD | 33,102,000USD | 5,271,000USD | 1,847,000USD |
| Reconciled Depreciation | 96,998,000USD | 30,894,000USD | 33,102,000USD | 5,271,000USD | 1,846,888USD |
| Total Other Income Expense Net | 114,371,000USD | 63,178,000USD | 22,588,000USD | 1,802,000USD | 1,906,000USD |
| Interest Expense | — | — | 4,045,000USD | 6,511,000USD | 209,000USD |
| Non Operating Income Net Other | — | — | 22,588,000USD | — | — |
| Net Income Applicable To Common Shares | — | — | 158,519,000USD | 118,918,000USD | -2,210,696USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,307,575,000USD | 1,307,112,000USD | 1,356,950,000USD | 1,355,992,000USD | 1,402,061,000USD | 1,344,208,000USD | 1,360,553,000USD | 1,392,828,000USD |
| Cash And Equivalents | 120,065,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 540,104,000USD | 504,732,000USD | 533,826,000USD | 495,672,000USD | 553,078,000USD | 605,266,000USD | 625,614,000USD | 643,139,000USD |
| Total Current Assets | 679,230,000USD | 664,596,000USD | 728,232,000USD | 695,140,000USD | 742,145,000USD | 764,978,000USD | 751,370,000USD | 742,883,000USD |
| Other Current Assets | 95,529,000USD | 36,279,000USD | 34,670,000USD | 40,108,000USD | 35,700,000USD | 33,098,000USD | 33,626,000USD | 36,508,000USD |
| Other Non Current Assets | 62,103,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 411,555,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 53,189,000USD | 47,294,000USD | 64,307,000USD | 68,804,000USD | 67,023,000USD | 75,396,000USD | 76,612,000USD | 79,568,000USD |
| Other Non Current Liabilities | 9,714,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 896,020,000USD | 938,083,000USD | 966,904,000USD | 964,038,000USD | 1,007,076,000USD | 1,022,982,000USD | 1,056,084,000USD | 1,078,094,000USD |
| Total Equity Including Noncontrolling Interest | 896,020,000USD | — | — | — | — | — | — | — |
| Deferred Revenue | 20,705,000USD | — | — | — | — | — | — | — |
| Deferred Revenue Non Current | 40,450,000USD | — | — | — | — | — | — | — |
| Goodwill | 47,806,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 36,530,000USD | 37,460,000USD | 38,381,000USD | 39,321,000USD | 40,262,000USD | 41,192,000USD | 42,113,000USD | 52,577,000USD |
| Common Stock | 821,242,000USD | 816,533,000USD | 802,341,000USD | 794,469,000USD | 791,668,000USD | 790,068,000USD | 777,171,000USD | 772,832,000USD |
| Retained Earnings | -128,074,000USD | -72,647,000USD | -29,482,000USD | -20,537,000USD | 36,582,000USD | 71,309,000USD | 116,930,000USD | 151,140,000USD |
| Accumulated Other Comprehensive Income | -3,152,000USD | -2,419,000USD | -4,234,000USD | -2,698,000USD | -2,657,000USD | -6,998,000USD | -4,378,000USD | -1,232,000USD |
| Total Liab | — | 369,029,000USD | 390,046,000USD | 391,954,000USD | 394,985,000USD | 321,226,000USD | 304,469,000USD | 314,734,000USD |
| Other Current Liab | — | 3,926,000USD | 10,755,000USD | 7,234,000USD | 4,965,000USD | 11,958,000USD | 16,462,000USD | 26,209,000USD |
| Capital Stock | — | 816,533,000USD | 802,341,000USD | 794,469,000USD | 791,668,000USD | 790,068,000USD | 777,171,000USD | 772,832,000USD |
| Good Will | — | 47,806,000USD | 47,806,000USD | 47,806,000USD | 47,806,000USD | 47,806,000USD | 47,806,000USD | 47,806,000USD |
| Cash | — | 77,063,000USD | 128,513,000USD | 83,159,000USD | 92,437,000USD | 159,266,000USD | 156,325,000USD | 126,640,000USD |
| Current Deferred Revenue | — | 16,691,000USD | 22,509,000USD | 24,630,000USD | 25,121,000USD | 25,997,000USD | 21,179,000USD | 13,439,000USD |
| Net Debt | — | 63,115,000USD | 14,705,000USD | 59,059,000USD | 49,643,000USD | -91,419,000USD | -90,961,000USD | -55,241,000USD |
| Short Term Debt | — | 5,869,000USD | 5,815,000USD | 5,166,000USD | 4,896,000USD | 4,637,000USD | 4,621,000USD | 5,125,000USD |
| Short Long Term Debt Total | — | 140,178,000USD | 143,218,000USD | 142,218,000USD | 142,080,000USD | 67,847,000USD | 65,364,000USD | 71,399,000USD |
| Long Term Investments | — | 65,308,000USD | 62,580,000USD | 93,301,000USD | 90,374,000USD | 81,567,000USD | 82,297,000USD | 84,084,000USD |
| Short Term Investments | — | 427,669,000USD | 405,313,000USD | 412,513,000USD | 460,641,000USD | 446,000,000USD | 469,289,000USD | 516,499,000USD |
| Net Receivables | — | 115,725,000USD | 153,400,000USD | 159,360,000USD | 153,367,000USD | 126,614,000USD | 92,130,000USD | 63,236,000USD |
| Inventory | — | 7,860,000USD | 6,336,000USD | — | — | — | 0USD | — |
| Accounts Payable | — | 20,808,000USD | 25,228,000USD | 31,774,000USD | 32,041,000USD | 32,804,000USD | 34,350,000USD | 34,795,000USD |
| Property Plant Equipment Net | — | 422,806,000USD | 428,003,000USD | 427,358,000USD | 424,020,000USD | 347,102,000USD | 340,429,000USD | 331,263,000USD |
| Property Plant Equipment Gross | — | 486,340,000USD | 485,617,000USD | 479,985,000USD | 472,534,000USD | 391,081,000USD | 380,147,000USD | 369,981,000USD |
| Common Stock Shares Outstanding | — | 303,074,605shares | 298,707,082shares | 298,875,174shares | 298,508,601shares | 297,692,663shares | 294,589,739shares | 294,851,945shares |
| Non Current Assets Total | — | 642,516,000USD | 628,718,000USD | 660,852,000USD | 659,916,000USD | 579,230,000USD | 609,183,000USD | 649,945,000USD |
| Non Current Liabilities Total | — | 321,735,000USD | 325,739,000USD | 323,150,000USD | 327,962,000USD | 245,830,000USD | 227,857,000USD | 235,166,000USD |
| Non Current Liabilities Other | — | 11,321,000USD | 4,768,000USD | 1,386,000USD | 1,560,000USD | 1,624,000USD | 1,469,000USD | 1,524,000USD |
| Non Currrent Assets Other | — | 69,136,000USD | 51,948,000USD | 53,066,000USD | 57,454,000USD | 61,563,000USD | 96,538,000USD | 134,215,000USD |
| Net Working Capital | — | 617,302,000USD | 663,925,000USD | 626,336,000USD | 675,122,000USD | 689,582,000USD | 674,758,000USD | 663,315,000USD |
| Unclassified Non Current Liabilities | — | 310,414,000USD | 320,971,000USD | 321,764,000USD | 326,402,000USD | 244,206,000USD | 226,388,000USD | 233,642,000USD |
| Unclassified Equity | — | -619,917,000USD | -604,062,000USD | -601,665,000USD | -610,185,000USD | -621,465,000USD | -610,810,000USD | -617,478,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,356,950,000USD | 1,360,553,000USD | 1,488,094,000USD | 1,540,907,000USD | 1,318,569,000USD | 1,005,536,000USD | 23,488,000USD | 21,492,175USD |
| Intangible Assets | 38,381,000USD | 42,113,000USD | 120,425,000USD | 131,502,000USD | 148,392,000USD | 115,153,000USD | — | — |
| Other Current Assets | 34,670,000USD | 33,626,000USD | 45,911,000USD | 34,064,000USD | 30,293,000USD | 4,073,000USD | 2,800,000USD | 3,313,494USD |
| Total Liab | 390,046,000USD | 304,469,000USD | 335,776,000USD | 307,630,000USD | 292,836,000USD | 175,028,000USD | 13,236,000USD | 9,882,972USD |
| Total Stockholder Equity | 966,904,000USD | 1,056,084,000USD | 1,152,318,000USD | 1,233,277,000USD | 1,025,733,000USD | 830,508,000USD | 10,252,000USD | 11,609,203USD |
| Other Current Liab | 10,755,000USD | 16,462,000USD | 68,388,000USD | 76,297,000USD | 58,881,000USD | 51,622,000USD | 3,365,000USD | 50,116USD |
| Common Stock | 802,341,000USD | 777,171,000USD | 753,199,000USD | 734,365,000USD | 722,430,000USD | 710,387,000USD | 5,122,000USD | 5,073,692USD |
| Capital Stock | 802,341,000USD | 777,171,000USD | 753,199,000USD | 734,365,000USD | 722,430,000USD | 710,387,000USD | 12,667,604USD | 12,630,699USD |
| Retained Earnings | -29,482,000USD | 116,930,000USD | 279,787,000USD | 426,185,000USD | 267,666,000USD | 114,202,000USD | -4,716,000USD | -2,504,936USD |
| Good Will | 47,806,000USD | 47,806,000USD | 47,806,000USD | 47,806,000USD | 47,806,000USD | 31,500,000USD | — | — |
| Cash | 128,513,000USD | 156,325,000USD | 133,320,000USD | 386,535,000USD | 476,142,000USD | 594,116,000USD | 7,553,000USD | 10,444,283USD |
| Cash And Short Term Investments | 533,826,000USD | 625,614,000USD | 760,585,000USD | 886,485,000USD | 722,977,000USD | 594,116,000USD | 7,553,000USD | 10,444,283USD |
| Total Current Assets | 728,232,000USD | 751,370,000USD | 871,985,000USD | 1,025,491,000USD | 929,800,000USD | 813,325,000USD | 12,640,000USD | 15,162,234USD |
| Total Current Liabilities | 64,307,000USD | 76,612,000USD | 119,013,000USD | 118,320,000USD | 120,676,000USD | 103,490,000USD | 7,895,000USD | 6,433,381USD |
| Current Deferred Revenue | 22,509,000USD | 21,179,000USD | 18,958,000USD | 21,612,000USD | 7,536,000USD | 7,531,000USD | 3,268,000USD | 2,333,695USD |
| Net Debt | 14,705,000USD | -90,961,000USD | -55,940,000USD | -304,277,000USD | -436,077,000USD | -587,338,000USD | -662,000USD | -7,001,709USD |
| Short Term Debt | 5,815,000USD | 4,621,000USD | 6,158,000USD | 5,583,000USD | 3,652,000USD | 865,000USD | 2,886,000USD | 2,531,350USD |
| Short Long Term Debt Total | 143,218,000USD | 65,364,000USD | 77,380,000USD | 82,258,000USD | 40,065,000USD | 6,778,000USD | 6,891,000USD | 3,442,574USD |
| Long Term Investments | 62,580,000USD | 82,297,000USD | 65,938,000USD | 72,522,000USD | 50,313,000USD | 19,247,000USD | — | — |
| Short Term Investments | 405,313,000USD | 469,289,000USD | 627,265,000USD | 499,950,000USD | 246,835,000USD | 594,116,000USD | — | — |
| Net Receivables | 153,400,000USD | 92,130,000USD | 64,382,000USD | 103,410,000USD | 174,858,000USD | 213,728,000USD | 2,124,000USD | 1,404,457USD |
| Inventory | 6,336,000USD | 0USD | 1,107,000USD | 1,532,000USD | 1,672,000USD | 1,408,000USD | 163,000USD | 1USD |
| Accounts Payable | 25,228,000USD | 34,350,000USD | 25,509,000USD | 14,828,000USD | 14,924,000USD | 7,320,000USD | 1,644,000USD | 1,518,220USD |
| Property Plant Equipment Net | 428,003,000USD | 340,429,000USD | 287,696,000USD | 217,255,000USD | 111,616,000USD | 17,923,000USD | 8,480,000USD | 6,329,941USD |
| Property Plant Equipment Gross | 485,617,000USD | 380,147,000USD | 318,304,000USD | 235,730,000USD | 121,442,000USD | 17,923,000USD | 8,479,940USD | 6,329,941USD |
| Accumulated Other Comprehensive Income | -4,234,000USD | -4,378,000USD | -1,720,000USD | -1,391,000USD | 280,000USD | 0USD | 0USD | -1,552,878USD |
| Common Stock Shares Outstanding | 298,707,082shares | 294,327,532shares | 289,166,486shares | 314,827,255shares | 318,294,236shares | 263,129,765shares | 237,723,530shares | 151,036,370shares |
| Non Current Assets Total | 628,718,000USD | 609,183,000USD | 616,109,000USD | 515,416,000USD | 388,769,000USD | 192,211,000USD | 10,848,000USD | 6,329,941USD |
| Non Current Liabilities Total | 325,739,000USD | 227,857,000USD | 216,763,000USD | 189,310,000USD | 172,160,000USD | 71,538,000USD | 5,341,000USD | 3,449,591USD |
| Non Current Liabilities Other | 4,768,000USD | 1,469,000USD | 5,906,000USD | 3,086,000USD | 134,790,000USD | 4,422,000USD | — | 277,134USD |
| Non Currrent Assets Other | 51,948,000USD | 96,538,000USD | 94,244,000USD | 41,031,000USD | 23,234,000USD | 1,710,000USD | 2,368,000USD | — |
| Net Working Capital | 663,925,000USD | 674,758,000USD | 752,972,000USD | 907,171,000USD | 809,124,000USD | 709,835,000USD | 4,745,476USD | 8,728,853USD |
| Unclassified Non Current Liabilities | 320,971,000USD | 226,388,000USD | 210,857,000USD | 40,411,000USD | -134,014,000USD | — | 2,641,658USD | — |
| Unclassified Equity | -604,062,000USD | -610,810,000USD | -632,147,000USD | -660,247,000USD | -687,073,000USD | -704,468,000USD | -2,821,604USD | -2,037,374USD |
| Deferred Long Term Liab | — | — | — | 33,178,000USD | 37,370,000USD | — | — | — |
| Other Liab | — | — | — | 112,635,000USD | 134,014,000USD | 65,625,000USD | 1,336,199USD | 2,538,367USD |
| Other Assets | — | — | — | 84,431,000USD | 30,642,000USD | 8,388,000USD | 2,367,795USD | — |
| Net Tangible Assets | — | — | — | 1,053,969,000USD | 829,535,000USD | 683,855,000USD | 2,706,297USD | 4,052,196USD |
| Unclassified Non Current Assets | — | — | — | -79,131,000USD | -23,234,000USD | — | -2,367,795USD | — |
| Unclassified Current Liabilities | — | — | — | — | 35,683,000USD | 35,962,000USD | -5,734,982USD | -2,531,350USD |
| Short Long Term Debt | — | — | — | — | — | 190,000USD | 2,466,982USD | 2,531,350USD |
| Long Term Debt | — | — | — | — | — | 2,198,000USD | 1,363,143USD | 911,224USD |
| Unclassified Current Assets | — | — | — | — | — | -594,116,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -43,165,000USD | -8,945,000USD | -57,119,000USD | -34,727,000USD | -45,621,000USD | -34,210,000USD | -51,107,000USD | -36,930,000USD |
| Depreciation | 8,655,000USD | 8,986,000USD | 7,236,000USD | 7,060,000USD | 6,605,000USD | -18,100,000USD | 38,295,000USD | 38,037,000USD |
| Stock Based Compensation | 12,013,000USD | 12,904,000USD | 13,895,000USD | 14,207,000USD | 14,786,000USD | 15,226,000USD | 17,164,000USD | 17,782,000USD |
| Other Non Cash Items | 2,377,000USD | -1,696,285USD | 1,531,000USD | -2,143,000USD | 2,213,000USD | 44,999,000USD | -10,367,377USD | -22,778,572USD |
| Change To Account Receivables | 13,103,000USD | -39,537,853USD | 4,155,000USD | -18,979,000USD | -1,133,000USD | -20,861,000USD | -19,856,271USD | -15,614,318USD |
| Change In Working Capital | -13,403,000USD | -45,991,715USD | -18,137,000USD | -16,801,000USD | 10,463,000USD | -15,915,000USD | -5,818,039USD | -7,787,207USD |
| Total Cash From Operating Activities | -33,523,000USD | -34,743,000USD | -52,594,000USD | -32,404,000USD | -11,554,000USD | -8,000,000USD | -28,997,416USD | -29,458,779USD |
| Capital Expenditures | -3,831,000USD | -9,843,000USD | -8,928,000USD | -13,365,000USD | -10,636,000USD | -15,630,000USD | -18,584,583USD | -19,796,850USD |
| Free Cash Flow | -37,354,000USD | -44,586,000USD | -61,522,000USD | -45,769,000USD | -22,190,000USD | -23,630,000USD | -47,582,000USD | -49,255,630USD |
| Investments | -22,611,000USD | 7,874,000USD | 36,488,000USD | -31,811,000USD | 7,935,000USD | 35,703,000USD | 3,698,000USD | 52,098,000USD |
| Total Cashflows From Investing Activities | -25,081,000USD | 75,138,000USD | 36,488,000USD | -31,811,000USD | 7,935,000USD | 35,703,000USD | 3,944,408USD | 51,517,648USD |
| Total Cash From Financing Activities | 7,192,000USD | 4,115,000USD | 7,372,000USD | -3,375,000USD | 5,970,000USD | 4,142,000USD | 3,150,180USD | 2,612,205USD |
| Change In Cash | -52,950,000USD | 44,800,000USD | -9,278,000USD | -66,829,000USD | 2,941,000USD | 29,685,000USD | -21,672,000USD | 24,740,000USD |
| Begin Period Cash Flow | 155,013,000USD | 110,449,000USD | 119,727,000USD | 186,556,000USD | 183,615,000USD | 153,930,000USD | 173,312,000USD | 148,572,000USD |
| End Period Cash Flow | 102,063,000USD | 155,249,000USD | 110,449,000USD | 119,727,000USD | 186,556,000USD | 183,615,000USD | 151,640,000USD | 173,312,000USD |
| Other Cashflows From Investing Activities | 1,361,000USD | 93,645,000USD | 918,000USD | 5,430,000USD | 2,901,000USD | 6,558,000USD | 9,426,186USD | 12,442,233USD |
| Other Cashflows From Financing Activities | 7,192,000USD | -6,409,000USD | -182,000USD | -8,880,000USD | -178,000USD | -177,000USD | 7,384,937USD | -180,395USD |
| Unclassified Investing Cash Flow | — | -16,538,000USD | 8,010,000USD | 7,935,000USD | 7,735,000USD | 9,072,000USD | 9,404,805USD | 6,774,265USD |
| Unclassified Financing Cash Flow | — | 10,524,000USD | 7,554,000USD | 5,505,000USD | 6,148,000USD | 5,899,000USD | -4,234,757USD | 2,792,600USD |
| Sale Purchase Of Stock | — | — | — | — | — | -1,580,000USD | — | — |
| Unclassified Operating Cash Flow | — | — | — | — | — | — | -17,164,000USD | -17,782,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -146,412,000USD | -162,857,000USD | -146,398,000USD | 158,519,000USD | 153,464,000USD | 118,918,000USD | -2,211,000USD | 309,000USD |
| Depreciation | 22,171,000USD | 96,998,000USD | 30,894,000USD | 33,102,000USD | 17,250,000USD | 5,271,000USD | 1,847,000USD | 918,000USD |
| Stock Based Compensation | 55,792,000USD | 67,581,000USD | 64,183,000USD | 49,481,000USD | 30,646,000USD | 8,397,000USD | 890,000USD | 615,000USD |
| Other Non Cash Items | 7,848,000USD | -84,435,000USD | -7,741,000USD | 8,547,000USD | 3,570,000USD | 4,707,000USD | 194,000USD | -188,000USD |
| Change To Account Receivables | -55,623,000USD | -75,119,000USD | -45,933,000USD | -22,715,000USD | 22,478,000USD | -203,020,000USD | -1,803,000USD | -477,000USD |
| Change In Working Capital | -70,694,000USD | -25,843,000USD | 13,225,000USD | 29,825,000USD | 41,672,000USD | -116,701,000USD | 1,974,000USD | 1,911,000USD |
| Total Cash From Operating Activities | -131,295,000USD | -108,556,000USD | -43,877,000USD | 277,360,000USD | 244,584,000USD | 22,690,000USD | 2,694,000USD | 3,565,000USD |
| Capital Expenditures | -42,772,000USD | -78,396,000USD | -77,507,000USD | -72,660,000USD | -58,452,000USD | -14,673,000USD | -3,997,000USD | -5,307,000USD |
| Free Cash Flow | -174,067,000USD | -186,952,000USD | -121,384,000USD | 204,700,000USD | 186,132,000USD | 8,017,000USD | -1,303,000USD | -1,742,000USD |
| Investments | 52,935,000USD | 121,409,000USD | -213,848,000USD | -352,625,000USD | -277,425,000USD | -19,247,000USD | -5,779,907USD | -5,307,066USD |
| Total Cashflows From Investing Activities | 87,750,000USD | 121,409,000USD | -221,108,000USD | -352,625,000USD | -332,247,000USD | -119,780,000USD | -5,780,000USD | -5,307,000USD |
| Total Cash From Financing Activities | 14,082,000USD | 12,769,000USD | 10,356,000USD | -1,628,000USD | -3,886,000USD | 683,653,000USD | 195,000USD | 12,186,000USD |
| Change In Cash | -28,366,000USD | 23,005,000USD | -254,040,000USD | -86,492,000USD | -92,974,000USD | 586,563,000USD | -2,891,000USD | 10,444,283USD |
| Begin Period Cash Flow | 183,615,000USD | 160,610,000USD | 414,650,000USD | 501,142,000USD | 594,116,000USD | 7,553,000USD | 10,444,000USD | -283USD |
| End Period Cash Flow | 155,249,000USD | 183,615,000USD | 160,610,000USD | 414,650,000USD | 501,142,000USD | 594,116,000USD | 7,553,000USD | 10,444,000USD |
| Other Cashflows From Investing Activities | 84,724,000USD | 35,708,000USD | 25,311,000USD | 16,434,000USD | 32,621,000USD | -3,217,000USD | -1,783,000USD | -1,783,019USD |
| Other Cashflows From Financing Activities | 14,082,000USD | -729,000USD | -1,234,000USD | -4,383,000USD | -7,550,000USD | 75,662,000USD | 25,000USD | 7,594,000USD |
| Unclassified Investing Cash Flow | -7,137,000USD | 42,688,000USD | 44,936,000USD | 56,226,000USD | -28,991,000USD | -82,643,000USD | 5,779,907USD | 7,090,085USD |
| Unclassified Financing Cash Flow | — | 13,498,000USD | — | 3,078,000USD | 4,626,154USD | 522,840,000USD | — | -7,557,154USD |
| Change To Inventory | — | — | 18,253,000USD | 40,919,000USD | 40,919,000USD | -134,348,000USD | -150,095USD | -897,770USD |
| Net Borrowings | — | — | 11,590,000USD | -323,000USD | -951,000USD | 85,151,000USD | 180,665USD | 1,980,154USD |
| Unclassified Operating Cash Flow | — | — | 1,960,000USD | — | — | 2,098,000USD | — | — |
| Change To Liabilities | — | — | — | -76,322,000USD | 21,175,000USD | 28,411,000USD | 1,736,467USD | 2,218,695USD |
| Issuance Of Capital Stock | — | — | — | 0USD | 522,839,000USD | 597,502,000USD | 0USD | 10,169,000USD |
| Cash And Cash Equivalents Changes | — | — | — | -76,893,000USD | -91,549,000USD | — | — | — |
| Sale Purchase Of Stock | — | — | — | — | -11,154USD | 0USD | -11,000USD | — |
| Dividends Paid | — | — | — | — | — | — | -14,161USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Product | Licensing And Royalty Revenue | 149,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Research Fees | 3,901,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Product | Licensing And Royalty Revenue | 191,000 | USD | 0001703057-26-000028 |
| Q1 2026Quarterly · 2026-03-31 | Product | Research Fees | 8,124,000 | USD | 0001703057-26-000028 |
| FY 2025Yearly · 2025-12-31 | Geography | Canada | 64,000,000 | USD | 0001703057-26-000012 |
| FY 2025Yearly · 2025-12-31 | Geography | United States | 11,100,000 | USD | 0001703057-26-000012 |
| FY 2025Yearly · 2025-12-31 | Product | License | 46,920,000 | USD | 0001703057-26-000012 |
| FY 2025Yearly · 2025-12-31 | Product | Milestone Payments | 1,000,000 | USD | 0001703057-26-000012 |
| FY 2025Yearly · 2025-12-31 | Product | Research Fees | 27,208,000 | USD | 0001703057-26-000012 |
| Q3 2025Quarterly · 2025-09-30 | Product | License | 138,000 | USD | 0001703057-25-000025 |
| Q3 2025Quarterly · 2025-09-30 | Product | Milestone Payments | 0 | USD | 0001703057-25-000025 |
| Q3 2025Quarterly · 2025-09-30 | Product | Research Fees | 8,817,000 | USD | 0001703057-25-000025 |
| Q2 2025Quarterly · 2025-06-30 | Product | License | 10,445,000 | USD | 0001703057-25-000011 |
| Q2 2025Quarterly · 2025-06-30 | Product | Milestone Payments | 0 | USD | 0001703057-25-000011 |
| Q2 2025Quarterly · 2025-06-30 | Product | Research Fees | 6,639,000 | USD | 0001703057-25-000011 |
| Q1 2025Quarterly · 2025-03-31 | Product | Licensing And Royalty Revenue | 167,000 | USD | 0001703057-26-000028 |
| Q1 2025Quarterly · 2025-03-31 | Product | Research Fees | 4,068,000 | USD | 0001703057-26-000028 |
| Q4 2024Quarterly · 2024-12-31 | Product | License | 281,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Milestone Payments | 0 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Research Fees | 4,768,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Geography | Canada | 26,200,000 | USD | 0001703057-26-000012 |
| FY 2024Yearly · 2024-12-31 | Geography | United States | 2,700,000 | USD | 0001703057-26-000012 |
| FY 2024Yearly · 2024-12-31 | Product | License | 1,049,000 | USD | 0001628280-25-008689 |
| FY 2024Yearly · 2024-12-31 | Product | Milestone Payments | 1,500,000 | USD | 0001628280-25-008689 |
| FY 2024Yearly · 2024-12-31 | Product | Research Fees | 26,284,000 | USD | 0001628280-25-008689 |
| FY 2024Yearly · 2024-12-31 | Product | Royalty | 0 | USD | 0001628280-25-008689 |
| Q3 2024Quarterly · 2024-09-30 | Product | License | 218,000 | USD | 0001703057-25-000025 |
| Q3 2024Quarterly · 2024-09-30 | Product | Milestone Payments | 0 | USD | 0001703057-25-000025 |
| Q3 2024Quarterly · 2024-09-30 | Product | Research Fees | 6,289,000 | USD | 0001703057-25-000025 |
| Q2 2024Quarterly · 2024-06-30 | Product | License | 370,000 | USD | 0001703057-25-000011 |
| Q2 2024Quarterly · 2024-06-30 | Product | Milestone Payments | 1,500,000 | USD | 0001703057-25-000011 |
| Q2 2024Quarterly · 2024-06-30 | Product | Research Fees | 5,453,000 | USD | 0001703057-25-000011 |
| FY 2023Yearly · 2023-12-31 | Geography | Canada | 36,000,000 | USD | 0001703057-26-000012 |
| FY 2023Yearly · 2023-12-31 | Geography | United States | 2,000,000 | USD | 0001703057-26-000012 |
| FY 2023Yearly · 2023-12-31 | Product | License | 969,000 | USD | 0001628280-25-008689 |
| FY 2023Yearly · 2023-12-31 | Product | Milestone Payments | 1,500,000 | USD | 0001628280-25-008689 |
| FY 2023Yearly · 2023-12-31 | Product | Research Fees | 35,556,000 | USD | 0001628280-25-008689 |
| FY 2023Yearly · 2023-12-31 | Product | Royalty | 0 | USD | 0001628280-25-008689 |
| FY 2022Yearly · 2022-12-31 | Geography | Canada | 484,200,000 | USD | 0001628280-25-008689 |
| FY 2022Yearly · 2022-12-31 | Geography | United States | 1,200,000 | USD | 0001628280-25-008689 |
| FY 2022Yearly · 2022-12-31 | Product | License | 696,000 | USD | 0001628280-25-008689 |
| FY 2022Yearly · 2022-12-31 | Product | Milestone Payments | 900,000 | USD | 0001628280-25-008689 |
| FY 2022Yearly · 2022-12-31 | Product | Research Fees | 40,802,000 | USD | 0001628280-25-008689 |
| FY 2022Yearly · 2022-12-31 | Product | Royalty | 443,026,000 | USD | 0001628280-25-008689 |
| FY 2021Yearly · 2021-12-31 | Geography | Canada | 353,400,000 | USD | 0001703057-24-000019 |
| FY 2021Yearly · 2021-12-31 | Geography | United States | 21,800,000 | USD | 0001703057-24-000019 |
| FY 2021Yearly · 2021-12-31 | Product | License | 20,778,000 | USD | 0001703057-24-000019 |
| FY 2021Yearly · 2021-12-31 | Product | Milestone Payments | 8,000,000 | USD | 0001703057-24-000019 |
| FY 2021Yearly · 2021-12-31 | Product | Research Fees | 19,076,000 | USD | 0001703057-24-000019 |
| FY 2021Yearly · 2021-12-31 | Product | Royalty | 327,349,000 | USD | 0001703057-24-000019 |
| FY 2020Yearly · 2020-12-31 | Product | Milestone Payments | 15,000,000 | USD | 0001564590-23-002128 |
| FY 2020Yearly · 2020-12-31 | Product | Research Fees | 19,848,000 | USD | 0001564590-23-002128 |
| FY 2020Yearly · 2020-12-31 | Product | Royalty | 198,307,000 | USD | 0001564590-23-002128 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.